MétaCan
Menu
Back to cohort
Record W3003354305 · doi:10.2147/opth.s235265

<p>Comparison of Iodide-125 and Ruthenium-106 Brachytherapy in the Treatment of Choroidal Melanomas</p>

2020· article· en· W3003354305 on OpenAlexaff
Fariba Ghassemi, Shahab Sheibani, Mojtaba Arjmand, Hosein Poorbaygi, Emad Kouhestani, Siamak Sabour, Farhad Samiei, Akbar Beiki‐Ardakani, Mahmoud Jabarvand, A Sadeghi Tari

Bibliographic record

VenueClinical ophthalmology · 2020
Typearticle
Languageen
FieldMedicine
TopicOcular Oncology and Treatments
Canadian institutionsPrincess Margaret Cancer Centre
FundersTehran University of Medical Sciences and Health Services
KeywordsMedicineBrachytherapyChoroidal melanomaOphthalmologyIodideNuclear medicineMelanomaInternal medicineCancer researchRadiation therapyChemistry

Abstract

fetched live from OpenAlex

Background: To compare iodine-125 ( 125 I) with ruthenium-106 ( 106 Ru) episcleral plaque radiation therapy in terms of the effectiveness and non-inferiority for choroidal melanoma treatment. Objective: To report the non-inferiority of new made iodine-125 ( 125 I) compared with ruthenium-106 ( 106 Ru) episcleral plaque radiation. Patients and Methods: A retrospective, non-randomized comparative case series. In this series the patients treated with 125 I and 106 Ru episcleral plaques for choroidal melanoma between September 2013 and August 2017 at Farabi Hospital are compared. Local control of choroidal melanomas after 125 I and 106 Ru plaques implantation and vision changes are the main outcome measures. Results: A total of 35 patients were identified ( 125 I = 15, 106 Ru = 20). No significant difference between two groups in visual acuity, diameter and thickness changes were observed after treatment. Multivariate linear regression (MLR) analysis showed that final diameter was only, independently and significantly, correlated with the pre-treatment diameter of the tumor (β = 0.59, 95% confidence interval [CI]: 0.29, 1.34, P = 0.003). The same MLR analysis for the final thickness and visual acuity, after adjusting for age and sex showed no significant difference between two groups. A single patient treated with 106 Ru had local tumor recurrence with no one in the 125 I group. No statistical difference in the rate of ocular complications was observed. Conclusion: The treatment with our 125 I plaques is as effective as 106 Ru plaques in controlling choroidal melanoma tumor and preserving the vision during the two and half year of follow-up. The complication rates are alike. It means that the effectiveness of 125 I is not only comparable to 106 Ru but also superior when the outcome of the interest is the thickness of the tumors. Keywords: brachytherapy, choroidal melanoma, complication, local tumor control, 125 I, radiation, 106 Ru, tumor size, vision preservation

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.025
Threshold uncertainty score0.583

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.098
GPT teacher head0.419
Teacher spread0.321 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations25
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueClinical ophthalmologySame topicOcular Oncology and TreatmentsFrench-language works237,207